Biotech Values

[apljack]

NXTM: Doesn't look like anyone follows this co. here (after my last post.) They are engaged in the manufacture of critical care and home-based dialysis products. Last quarter's report appears to be pleasing to the street and the share value has marched steadily up from $10/share to north of $12.50/share. I'm no technical analyst, but I like the behavior. The co. is worth a look. They have a new overnight dialysis product and a new rapid dialyzing product approved by the FDA. They also announced last quarter that they would stop selling product in the EU through vendors and start marketing them independently. Always an added expense, but better on the margins.

FWIW,

aj